Proteomic signatures of infiltrative gastric cancer by proteomic and bioinformatic analysis

被引:9
|
作者
Zhang, Li-Hua [1 ,2 ]
Zhuo, Hui-Qin [1 ]
Hou, Jing-Jing [1 ]
Zhou, Yang [1 ,2 ]
Cheng, Jia [1 ]
Cai, Jian-Chun [1 ,2 ]
机构
[1] Xiamen Univ, Sch Med, Zhongshan Hosp, Dept Gastrointestinal Surg, 201 Hubin Rd,Siming St, Xiamen 361004, Fujian, Peoples R China
[2] Xiamen Univ, Sch Med, Zhongshan Hosp, Inst Gastrointestinal Oncol, Xiamen 361004, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
Infiltrative gastric cancer; Proteomics; Molecular biological characteristics; Ming's classification; Bioinformatic analysis; MING CLASSIFICATION; GROWTH; LAUREN;
D O I
10.4251/wjgo.v14.i11.2097
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND Proteomic signatures of Ming's infiltrative gastric cancer (IGC) remain unknown. AIM To elucidate the molecular characteristics of IGC at the proteomics level. METHODS Twelve pairs of IGC and adjacent normal tissues were collected and their proteomes were analyzed by high performance liquid chromatography tandem mass spectrometry. The identified peptides were sequenced de novo and matched against the SwissProt database using Maxquant software. The differentially expressed proteins (DEPs) were screened using |log2(Fold change)| > 1 and P-adj < 0.01 as the thresholds. The expression levels of selected proteins were verified by Western blotting. The interaction network of the DEPs was constructed with the STRING database and visualized using Cytoscape with cytoHubba software. The DEPs were functionally annotated using clusterProfiler, STRING and DAVID for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. P < 0.05 was considered statistically significant. RESULTS A total of 7361 DEPs were identified, of which 94 were significantly up-regulated and 223 were significantly down-regulated in IGC relative to normal gastric tissues. The top 10 up-regulated proteins were MRTO4, BOP1, PES1, WDR12, BRIX1, NOP2, POLR1C, NOC2L, MYBBP1A and TSR1, and the top 10 down-regulated proteins were NDUFS8, NDUFS6, NDUFA8, NDUFA5, NDUFC2, NDUFB8, NDUFB5, NDUFB9, UQCRC2 and UQCRC1. The up-regulated proteins were enriched for 9 biological processes including DNA replication, ribosome biogenesis and initiation of DNA replication, and the cellular component MCM complex. Among the down-regulated proteins, 17 biological processes were enriched, including glucose metabolism, pyruvic acid metabolism and fatty acid beta-oxidation. In addition, the mitochondrial inner membrane, mitochondrial matrix and mitochondrial proton transport ATP synthase complex were among the 6 enriched cellular components, and 11 molecular functions including reduced nicotinamide adenine dinucleotide dehydrogenase activity, acyl-CoA dehydrogenase activity and nicotinamide adenine dinucleotide binding were also enriched. The significant KEGG pathways for the up-regulated proteins were DNA replication, cell cycle and mismatch repair, whereas 18 pathways including oxidative phosphorylation, fatty acid degradation and phenylalanine metabolism were significantly enriched among the down-regulated proteins. CONCLUSION The proteins involved in cell cycle regulation, DNA replication and mismatch repair, and metabolism were significantly altered in IGC, and the proteomic profile may enable the discovery of novel biomarkers.
引用
收藏
页码:2097 / 2107
页数:11
相关论文
共 50 条
  • [31] Comparative Analysis of Acquired Resistance to Bortezomib in Prostate Cancer Cells Using Proteomic and Bioinformatic Tools
    Seker, Semih
    Sahin, Betul
    Yerlikaya, Azmi
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2025, 29 (01)
  • [32] Serum proteomic fingerprints for diagnosis of gastric cancer
    Leung, WK
    Poon, TC
    Ng, EK
    Chow, SM
    Yu, AC
    Chu, ES
    Sung, JJ
    GASTROENTEROLOGY, 2005, 128 (04) : A71 - A71
  • [33] Integrating genomic, proteomic, and bioinformatic analyses for cancer drug discovery.
    Weinstein, JN
    Reinhold, WC
    Nishizuka, S
    Bussey, K
    Kohn, KW
    Pommier, Y
    Zeeberg, B
    Kim, S
    Lababidi, S
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6124S - 6124S
  • [34] Diagnosis of gastric cancer by serum proteomic fingerprinting
    Poon, Terence C. W.
    Sung, Joseph J. Y.
    Chow, Shuk M.
    Ng, Enders K. W.
    Yu, Alex C. W.
    Chu, Eagle S. H.
    Hui, Angela M. Y.
    Leung, Wai K.
    GASTROENTEROLOGY, 2006, 130 (06) : 1858 - 1864
  • [35] Proteomic study on nintedanib in gastric cancer cells
    Dong, Xiaohua
    Wang, Liuli
    Wang, Da
    Yu, Miao
    Yang, Xiao Jun
    Cai, Hui
    PEERJ, 2024, 12
  • [36] Proteomic approaches for biomarkers discovery in gastric cancer
    Kam, S. Y.
    Ling, A. M. M.
    Wong, W. K.
    Chan, W. H.
    Ong, H. S.
    Yap, W. M.
    Chau, Y. P.
    Lai, S. H.
    Kon, O. L.
    Ho, M. M. F.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S107 - S107
  • [37] SILAC-based quantitative proteomic analysis of gastric cancer secretome
    Marimuthu, Arivusudar
    Subbannayya, Yashwanth
    Sahasrabuddhe, Nandini A.
    Balakrishnan, Lavanya
    Syed, Nazia
    Sekhar, Nirujogi Raja
    Katte, Teesta V.
    Pinto, Sneha M.
    Srikanth, Srinivas M.
    Kumar, Praveen
    Pawar, Harsh
    Kashyap, Manoj K.
    Maharudraiah, Jagadeesha
    Ashktorab, Hassan
    Smoot, Duane T.
    Ramaswamy, Girija
    Kumar, Rekha V.
    Cheng, Yulan
    Meltzer, Stephen J.
    Carlos Roa, Juan
    Chaerkady, Raghothama
    Prasad, T. S. Keshava
    Harsha, H. C.
    Chatterjee, Aditi
    Pandey, Akhilesh
    PROTEOMICS CLINICAL APPLICATIONS, 2013, 7 (5-6) : 355 - 366
  • [38] PROTEOMIC ANALYSIS OF RECTAL CANCER
    Fornari, Gianni
    Franco, Pierfrancesco
    Corpillo, Davide
    Comandone, Alessandro
    ANNALS OF ONCOLOGY, 2004, 15 : 43 - 43
  • [39] Proteomic analysis of phosphorylation in cancer
    Ruprecht, Benjamin
    Lemeer, Simone
    EXPERT REVIEW OF PROTEOMICS, 2014, 11 (03) : 259 - 267
  • [40] Proteomic signatures in antibiotic research
    Wenzel, Michaela
    Bandow, Julia E.
    PROTEOMICS, 2011, 11 (15) : 3256 - 3268